What is the appropriate dose of MiraLAX (polyethylene glycol 3350) for a 3-year-old child weighing 48 pounds with constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

MiraLAX Dosing for a 48-Pound 3-Year-Old with Constipation

For a 3-year-old weighing 48 pounds (approximately 22 kg), start with 8.8 grams (0.4 g/kg) of MiraLAX once daily, mixed in at least 4-8 ounces of liquid, and adjust the dose every 3 days based on response to achieve 1-2 soft bowel movements daily. 1, 2

Weight-Based Dosing Calculation

  • A 48-pound child weighs approximately 22 kg (48 ÷ 2.2 = 21.8 kg) 2
  • The recommended starting dose is 0.4 g/kg/day, which equals approximately 8.8 grams for this child 2
  • This dose can be adjusted between 0.2-0.8 g/kg/day (4.4-17.6 grams) based on response, though doses above 0.6 g/kg may increase abdominal pain and fecal incontinence 2, 3
  • The average effective maintenance dose across multiple studies is 0.7-0.8 g/kg/day (15-18 grams for this child), allowing for gradual upward titration if needed 1, 3

Critical Administration Instructions

  • Mix the powder in at least 4-8 ounces of liquid—insufficient liquid volume is the most common cause of treatment failure 1
  • Acceptable liquids include water, juice, coffee, or tea; juices with sorbitol content (like prune or apple juice) provide synergistic osmotic effects 1
  • Ensure adequate daily fluid intake beyond just the mixing liquid, as PEG requires water to work osmotically 1, 4
  • Adjust the dose every 3 days as needed to achieve 2 soft stools per day 3

Pre-Treatment Assessment

  • Rule out fecal impaction by physical examination—if present, manual disimpaction or glycerin suppository may be required first 1
  • Exclude bowel obstruction or paralytic ileus before starting therapy 1
  • Confirm adequate daily fluid intake capability 1

Expected Response Timeline and Escalation

  • Most children respond within 3-4 days with increased bowel movement frequency and softer stool consistency 2, 3
  • If no bowel movement occurs after 3-4 days, add a bisacodyl suppository (10 mg) or glycerin suppository while continuing PEG 1, 4
  • For persistent constipation beyond this point, consider adding an oral stimulant laxative (senna or bisacodyl) to the PEG regimen 1, 4

Treatment Duration and Maintenance

  • Continue maintenance dosing once bowel movements normalize rather than stopping abruptly 1
  • PEG is safe and effective for 6-12 months or longer in children, with an average treatment duration of 8.4 months in pediatric studies 1
  • The average effective long-term dose is 0.7-0.8 g/kg/day, allowing for gradual dose reduction once response is established 1

Safety Profile and Side Effects

  • PEG is well-tolerated with minimal side effects 2, 3, 5
  • Transient diarrhea may occur (reported in 9-16% of patients) and typically resolves with dose adjustment 6, 5
  • Abdominal distension, flatulence, and nausea are generally mild 1
  • Higher doses (0.8 g/kg) are associated with more abdominal pain and fecal incontinence 2

Common Clinical Pitfalls to Avoid

  • Inadequate liquid volume (less than 4-8 ounces) significantly reduces efficacy 1, 4
  • Not confirming adequate daily fluid intake beyond the mixing liquid leads to treatment failure 1, 4
  • Assuming treatment failure without first optimizing dose and ensuring compliance 1
  • Delaying rectal intervention beyond 3-4 days without a bowel movement increases fecal impaction risk 1, 4
  • Premature discontinuation once symptoms improve—continue maintenance therapy for several months 1

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.